|
|
| Phases of Development | Discovery | Preclinical | IND | Phase I | Phase I/II | Phase II | Marketed |
|---|
| Autoimmune | 0 | 1 | 0 | 1 | 1 | 1 | 0 | | Cancer | 0 | 0 | 2 | 3 | 0 | 1 | 0 | | Dermatology | 0 | 0 | 0 | 0 | 0 | 1 | 0 | | Endocrine / Metabolic | 0 | 0 | 0 | 0 | 0 | 1 | 0 | | Inflammation | 2 | 0 | 0 | 1 | 0 | 0 | 0 | | Musculoskeletal | 0 | 1 | 0 | 1 | 0 | 0 | 0 | | Neurology | 0 | 2 | 0 | 0 | 0 | 0 | 0 | | Other | 0 | 0 | 0 | 0 | 0 | 0 | 1 | | Pulmonary | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
|
|

Products Targeting NF-kappa B (NF-kB)